JD Vance is desperate to shore up support among House Republicans for a spending bill that will keep the government open for ...

Any momentary market gains boosted by Trump’s return to the Oval Office have since vanished. The S&P 500 has lost 6.4 percent ...

Staff at the U.S. Agency for International Development have received an alarming order on what to do with their classified ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found. Researchers have taken a major step towards producing a more affordable and lower ...

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein shell of poliovirus, but ...

“The global polio vaccines market, valued at US$ 794.1 Mn in 2023, is projected to grow at a CAGR of 5.0% from 2024 to 2034, reaching an estimated US$ 1.4 Bn by the end of 2034.” Governments worldwide ...

According to healthychildren.org, childhood vaccines consistently remain at very high and beneficial levels of safety and efficacy.